Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | CA3 | P07451 | 2/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CA6 | P23280 | 2/20 | 0.56 |
| ▸ | CA5A | P35218 | 2/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | SELL | P14151 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3461631 | 0.88 | TTR (0.78) | TTRCA12CA1CA2CA7 | |
| SCHEMBL29373087 | 0.88 | TTR (0.78) | TTRCA12CA1CA2CA7 | |
| SCHEMBL5988761 | 0.84 | TTR (0.72) | TTRCA12CA1CA2CA7 | |
| SCHEMBL21837082 | 0.84 | TTR (0.72) | TTRCA12CA1CA2CA7 | |
| SCHEMBL28317225 | 0.84 | TTR (0.72) | TTRCA12CA1CA2CA7 | |
| SCHEMBL987210 | 0.84 | TTR (0.72) | TTRCA12CA1CA2CA7 | |
| SCHEMBL4458695 | 0.81 | TTR (0.68) | TTRTDP1ALDH1A1MAPTMAPK1 | |
| SCHEMBL7122207 | 0.81 | TTR (0.68) | TTRCA12CA1CA2CA7 | |
| SCHEMBL25385602 | 0.81 | TTR (0.67) | TTRCA12CA1CA2CA7 | |
| SCHEMBL16077698 | 0.81 | TTR (0.67) | TTRCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026042014-A1 | A PHOTOCURABLE ACRYLATE RESIN MONOMER AND THE USE THEREOF | LEVOBIO LIMITED (CN) | 2026-02-26 | — | — | WO | claimed |
| WO-2025217089-A1 | ODORIZED FLUIDS AND METHODS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025137459-A1 | METHODS OF TREATING PAIN USING SENOLYTICS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-06-26 | — | — | WO | claimed |
| CN-119468861-A | Quantitative dividing method for succession stages of natural secondary forest | 河北农业大学 | 2025-02-18 | — | — | CN | claimed |
| CN-119409568-A | Preparation method of gallic acid and derivatives | 邵永久 | 2025-02-11 | — | — | CN | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117701479-B | Bacterial strain capable of degrading benzonitrile herbicide, microbial agent and application thereof | 华南农业大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117630204-A | Method for measuring and analyzing generation and mechanism of soluble microorganism product and disinfection by-product | 深圳大学 | 2024-03-01 | — | — | CN | claimed |
| CN-117248298-A | Spandex with yellowing resistance and preparation method thereof | 华峰化学股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117186043-A | Industrial synthesis method of high-purity benzbromarone | 成都倍特药业股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-112094200-A | Synthesis method of bromoxynil octanoate | 盐城优禾嘉农业科技有限公司 | 2020-12-18 | — | — | CN | claimed |
| CN-111875692-A | Rare crucian transthyretin protein gene, protein sequence and application thereof | 南京理工大学 | 2020-11-03 | — | — | CN | claimed |
| CN-111533718-A | Method for preparing benzbromarone | 浙江海洲制药有限公司 | 2020-08-14 | — | — | CN | claimed |
| CN-107523580-B | Halogenated p-hydroxybenzoic acid oxidative decarboxylase gene odcA and application thereof | 南京农业大学 | 2020-06-09 | — | — | CN | claimed |
| US-20090117493-A1 | Anti-Reflective Coating Forming Composition Containing Reaction Product of Isocyanuric Acid Compound with Benzoic Acid Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-05-07 | — | — | US | claimed |
| EP-1939688-A1 | COMPOSITION FOR ANTIREFLECTION FILM FORMATION, COMPRISING PRODUCT OF REACTION BETWEEN ISOCYANURIC ACID COMPOUND AND BENZOIC ACID COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2008-07-02 | — | — | EP | claimed |
| US-20070010579-A1 | Copper salts of organic acids and use thereof as fungicides | ISARGO S.P.A. (IT) | 2007-01-11 | — | — | US | claimed |
| WO-2003057896-A1 | METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| US-4218567-A | Process for aromatic ethers | HOFFMANN-LA ROCHE INC. (US) | 1980-08-19 | — | — | US | claimed |
| US-4043981-A | Copolyesters derived from ethoxylated 3,5-dibromo-4-hydroxybenzoic acid | EMERY INDUSTRIES, INC. (US) | 1977-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010579-A1 | Copper salts of organic acids and use thereof as fungicides | AOC3, AOC2, AOC1 | TTR 703/4885CA12 536/4885CA1 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.